Andrew Lees is founder of Fina Biosolutions LLC and is also an Associate Professor at the Center for Vaccine Development at the U of Maryland School of Medicine. He holds a BS in Chemistry from Harvey Mudd College ('76) and a Ph.D. in Biophysics from The Johns Hopkins University ('84) He is a Johns Hopkins Distinguished Alum and recipient of Harvey Mudd’s Outstanding Alumni Award. Much of Andrew’s career has focused on helping to make conjugate vaccines more affordable, including the development of CDAP chemistry and low-cost carrier proteins. He was formerly director of vaccine development at Biosynexus and Virion Systems.